(VELA) Study of BLU-222 in Advanced Solid Tumors
Blueprint Medicines Corporation
Blueprint Medicines Corporation
Eli Lilly and Company
Ohio State University Comprehensive Cancer Center
OHSU Knight Cancer Institute
City of Hope Medical Center
M.D. Anderson Cancer Center
NYU Langone Health
Medstar Health Research Institute
AIDS Malignancy Consortium
National Cancer Institute (NCI)
Case Comprehensive Cancer Center
Stanford University
Alliance for Clinical Trials in Oncology
AHS Cancer Control Alberta
Washington University School of Medicine
Stanford University